Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...
A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according to a study.
GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...
Obesity affects both physical and mental health, leading to body-image issues and emotional eating. Dr. Nand Kumar of AIIMS ...
Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...
Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...
The economic burden of obesity is also significant. In the Finger Lakes, excess medical spending due to obesity is estimated ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
13h
Bicycling on MSNNew Report Challenges Current Definition of ObesityOne of the inadequacies of using body mass index (BMI) as a predictive factor is that “current BMI-based measures of obesity can both underestimate and overestimate” a persons ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results